NEW YORK (GenomeWeb) – Response Genetics today disclosed that its stock has been delisted from the Nasdaq and will now trade on the Over-the-Counter Bulletin Board.

In late December, the company said that its shares were facing delisting for failing to meet the Nasdaq's $1 minimum bid price requirement. The company had previously been notified that it also did not meet the exchange's minimum $2.5 million in stockholders’ equity requirement

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.